波士顿科学在2023年第二季度实现了强劲的业绩增长,销售额同比增长23%至50.6亿美元,超过市场预期。其中,心血管设备销售额增长尤为显著,达到29%。净利润同比大幅增长约146%,调整后每股收益也超出分析师预期。基于此优异表现,公司上调了全年盈利指引,预计2025年的销售增长目标为在2024年167.5亿美元销售额的基础上增长18%至19%,同时将调整后每股收益指引从2.87至2.94美元上调至...
Source Link波士顿科学在2023年第二季度实现了强劲的业绩增长,销售额同比增长23%至50.6亿美元,超过市场预期。其中,心血管设备销售额增长尤为显著,达到29%。净利润同比大幅增长约146%,调整后每股收益也超出分析师预期。基于此优异表现,公司上调了全年盈利指引,预计2025年的销售增长目标为在2024年167.5亿美元销售额的基础上增长18%至19%,同时将调整后每股收益指引从2.87至2.94美元上调至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.